DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Perez EA, Romond EH, Suman VJ, Jeong JH, Sledge G, Geyer Jr CE. et al.
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.
J Clin Oncol 2014;
32: 3744-52
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.